Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone

<div>Clinical course. LEN, lenalidomide; RIT, rituximab; DEX, dexamethasone; sIL-2R, soluble interleukin-2 receptor; Hb, hemoglobin.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone 

Figure 1 | Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone 